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of the vascular structure. Binding to adhesion molec-
ules regulates the migration of leukocytes from the
blood stream into the vessel wall inflammatory diseases
[4]. Adhesion molecules seem also to play a role in
the migration of endothelial cells into the vessel wall
during angiogenesis, as well as the migration of vascu-
lar smooth muscle cells from the media into the intima
in chronic vascular disease. The surface expression of
the adhesion molecules is regulated by intracellular
free calcium concentration and protein kinase C. We
studied the effects of hyperlipoproteinema and
hyperglycemia, known risk factors of chronic vascular
disease, on the surface expression of adhesion molecules
on endothelial cells [12]. We could show that different
isozymes of the protein kinase C family are responsible
for phosphorylating and regulating the adhesion mole-
cules [13]. We also addressed the question whether or
not binding to adhesion molecules affects the intracellu-
lar signalling cascade and could show that binding to
the selectin family of adhesion molecules triggers
tyrosine phosphorylation in white blood cells [14].
Using FACS-analysis, we assessed the expression of
adhesion molecules on leukocytes in patients with
Wegener's Granulomatosis. We found that during
exacerbation of the disease there is increased expression
of the integrin receptors LFA-1 and VLA-4 on granulo-
cytes and monocytes in these patients [11]. Influencing
expression of adhesion molecules could be an import-
ant therapeutic approach in inflammatory vascular
diseases, as well as in chronic vascular diseases. We
are therefore investigating the possibilities of an anti-
sense strategy for inhibition of adhesion molecule
expression. For the gene transfer, virus-coated lipo-
somes (Sendai virus) are used in cell cultures and in
animal models. The aim of these studies is to interfere
with the complex alterations in inter- and intracellular
signalling in chronic diseases of the vascular wall and
to try to re-establish undisturbed cellular communica-
tion. In short, our laboratory is dedicated to establish
'who is talking to whom' in the vascular wall. We have
encountered inappropriate silence and unacceptable
shouting matches between the components. Our goal
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Plasma levels of inorganic phosphate (P;) are mainly
controlled by altering the rate of its proximal tubular
reabsorption [1]. The cellular mechanisms involved in
the proximal tubular handling of Pj have been charac-
terized by in vivo and in vitro microperfusion tech-
niques, by tissue culture experiments, and by studies
with isolated brush border and basolateral membrane
vesicles [1,13,14]. Uptake of Pj from the tubular lumen
into the epithelial cell is via sodium coupled Prtrans-
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port (Na/Prcotransport) mediating 'uphill' transport
of Pj. Transport across the basolateral membrane is
'equilibrating' involving multiple pathways, e.g. an
anion exchange mechanism and a Na/Prcotransporter(different from that/those in the apical membrane)
[13,14]. The transport mechanisms located in the
apical membrane are functionally and structurally well
defined (see below); the knowledge on the basolaterally
located transporters is rather limited. Physiological
regulation of proximal tubular Prreabsorption is most
likely entirely related to alterations in the function of
the apical transporter(s) [13,14].
Molecular characteristics of brush border
membrane Na/Prcotransport
In recent years we have isolated by an expression
cloning strategy different cDNAs encoding apical
Na/P;-cotransporters [11,15,19]. The key observation
in the cloning experiments was the increased uptake
of Pj in Xenopus laevis oocytes after injection of kidney
cortex mRNA [e.g. 11,19]. Cloning procedures led to
the functional identification of two different cDNA's:
The originally isolated NaP,-l cDNA was obtained
from a rabbit kidney cortex cDNA library [19]; later
a cDNA from a rat (NaPr2) and a human kidney
cortex library (NaPj-3) was isolated [11]. NaPr2- and
NaPj-3-proteins are highly homologous but different
from the NaPrl -protein [15]. Accordingly, two
structurally different Na/P;-cotransporters have been
identified: Type I (NaPrl) and Type II (NaPr2/3).
Subsequently homologs to either NaP;-l or NaPr2/3
have been isolated from a variety of species; interes-
tingly, the two transporters seem to coexist in the
kidney cortex of several species [15,18].
Functional characteristics
As the Type I (NaPrl) and Type II (NaPr2/3) trans-
porters have been obtained by functional screening
(increasing Na-dependent Pruptake) both proteins
are by definition Na/Prcotransporters. Nevertheless,
extensive further characterization of their transport
functions were performed. For the Type II transporters
a high selectivity for Pi5 a 3:1 stoichiometry (Na:P;)
and a strong pH-dependence (higher rates at more
alkaline pH-values) were found in tracer and
electrophysiological studies [2,15]. For the Type I trans-
porter no particular pH dependence was observed.
Furthermore, recent electrophysiological studies have
suggested that the Type I transporter might also trans-
port different organic anions (A. Busch et al., unpub-
lished). A comparison of the functional properties of
Type I and Type II transporters expressed in oocytes
with transport characteristics known from studies on
isolated brush border membrane vesicles suggests
that the Type II transporter is mainly responsible
for the 'apparent' properties of brush border Na/Pr
cotransport.
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Tissue localization
The cloning producure started from mRNA isolated
from kidney cortex. Thus, it was necessary to document
that the corresponding proteins (NaP,-l; NaP,-2) are
present in proximal tubular epithelial cells and there
in the apical membrane. For the Type I and Type II
transporters we could show that the mRNA encoding
these transporters are present in proximal tubular cells
and that the related proteins are located in the brush
border membrane [4,5,15; see also Figure 1]. Together
with above functional properties we conclude that the
Type II transporter is indeed the brush border mem-
brane Na/Pj-cotransporter; the Type I transporter is a
brush border transporter with broader specificity.
Structural properties
The Type I transporters are about 465 and the Type
II transporters are 635 amino acids in length [11,15,19].
Both transporters have several transmembrane
spanning regions (Type I: ~9; Type II: ~8) and are
glycosylated [6,15]. Both transporters contain con-
sensus sequence motifs for protein phosphorylations
[mostly kinase C sites; 7,11,15,19]. In studies on rat
brush border membrane vesicles we could show by
immunoprecipitation experiments that the NaP,-2 pro-
tein is a phosphoprotein [7]; such phosphorylation
reactions could be involved in protein kinase mediated
regulation of the transporter (see below).
Physiological regulation
Proximal tubular P,-reabsorption, and thus brush
border membrane Na/Pj-cotransport, is regulated by a
variety of hormonal and non-hormonal factors
[1,13,14]. We will only discuss briefly two examples:
Parathyroid hormone (PTH), as a known phosphat-
uric hormone, mediates its inhibitory action on Na/Pr
cotransport by activating a complex intracellular regu-
latory machinery; the initial step is interaction with a
hormone receptor capable of activating the adenylate
cyclase (protein kinase A) and the phospholipase-C
(protein kinase C) pathways [12]. The Type II Na/Pj-
cotransporter is a target for PTH regulation [8]. If the
rat II transporter is expressed in oocytes, Na/P,-
cotransporter activity is reduced by pharmacological
activation of protein kinase C but not of protein kinase
A [7]. However, we do not yet know whether this is
particular for the oocyte system and which of the
kinase sites might be involved in this regulation. In
tissue culture experiments we have generated evidence
for an involvement of an endocytic step in PTH-action
[14]. In immunohistochemical studies we documented
that infusion of PTH leads in rat proximal tubules to
an immediate removal of apical Na/Prcotransporters
and to their appearance in intracellular structures (also
in subapical vesicles; Figure 1) [8]. It is the task of
future experiments to determine the signalling events
linking the PTH-receptor occupancy to withdrawal
and inactivation of brush border membrane Na/Pj-
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Intact Intact + PTH (2 hours)
Fig. 1. Cross section through rat kidney cortex of control and PTH-infused animals. NaP,-2 antibody stains selectively the Type II Na/Pr
cotransporter [4] and appears as green fluorescence. An antibody recognizing (5-actin appears as red fluorescence. As seen in control
animals the Type II transporter is located mostly at brush border sites and appears as 'yellow' ('colocalization' of p-actin and transporter).
After PTH-treatment the transporter is removed from the brush border structure (red/P-actin) and appears now in intracellular compartments
(green; mostly subapical endosomes) [8].
cotransporters. The activity of the Type II Na/P;-
cotransporter is also under tight control of dietary
intake. Using molecular tools (antibodies; cDNA
probes) we could show that acute regulation (1 -2 h)
in rats fed either high or low Prdiets results in a
different surface expression (brush border membrane)
of the transporter protein most likely also involving
steps of membrane traffic. On the other hand, chronic
regulation ('adaptation', 4 h and more) involves also
transcriptional and translational mechanisms [10]. It
is evident that using the newly available molecular
tools we will start to understand a variety of such
regulatory mechanisms at a molecular level.
Genetic disorders
There are two well characterized inherited diseases
with impaired tubular phosphate reabsorption [e.g.
16]. We could show in the mouse model for X-linked
hypophosphatemic rickets (Hyp) that the Type II
transporter (in terms of its function, specific trans-
porter mRNA and protein) is reduced in affected
animals [17]. However, the Type II transporter is not
on chromosome X but on 5 [9]. Thus, the X-linked
factor controls either the transcription rate (or mRNA
stability) of the Type II transporter. The Type II
transporter is a candidate for being directly involved
in the autosomal form of hereditary hypophosphatemic
rickets. The Type I transporter has been localized in
the human to chromosome 6 [3]. On the basis of above
discussed 'general' functional characteristics of the
Type I transporter we do not think that it might play
a crucial role in these genetic disorders. Future experi-
ments (e.g. linkage studies and promoter/reporter gene
studies) will certainly clarify in the near future the
molecular mechanisms involved in the two described
hereditary forms of hypophosphatemia.
Perspectives
The newly developed molecular probes for the major
regulated Na/Prcotransporter of the brush border
membrane offers now the possibility to study at the
molecular level physiological and pathophysiological
regulation of renal proximal tubular Prreabsorption.
These studies will mainly go in three directions: (i) at
the protein level to understand hormonal (acute, pro-
tein kinase mediated) regulation of the transporter
including its membrane trafficking, (ii) At the level of
the gene organisation in order to understand regulatory
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mechanisms involving gene activation, (iii) At the level
of genetic aberations in order to understand the hered-
itary deflects. As a part of the latter experiments gene
knockout experiments (Type II transporter in mice)
might be relevant to understand the mechanisms of
pathophysiology of the different forms of hypo-
phosphatemia.
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The fibroblast—a (trans-) differentiated cell?
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Introduction
Renal fibrosis is one of the hallmarks of chronic renal
disease. It is characterized by excessive synthesis and
deposition of extracellular matrix substances such as
collagen types I and III, fibronectin, and proteoglycans.
Fibroblasts are—as the name implies—the main
effector cells in renal tubulointerstitial fibrosis. In 1867
Cohnheim published a classical paper on mechanisms
of inflammation, stating that fibroblasts (contractile
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cellular elements as they were called at the time) are
descendants of migrating leukocytes [1]. This theory
was widely held until 1970 when Ross, using parabiotic
rats, proved that fibroblasts are of local origin [2]. In
fact, today it is widely assumed that all renal fibroblasts
are derived from interstitial cells. However, recent
research demonstrates that fibroblasts may originate
from other cellular elements beside renal interstitial
cells. Almost 130 years after Cohnheim new aspects of
fibroblast origin are being discovered.
Is the fibroblast a differentiated cell?
Apart from the collecting duct cells, which are descend-
ants of the ureteric epithelium, all kidney cells are
